Results 101 to 110 of about 16,412,614 (252)

Factors influencing the performance of patient specific quality assurance for pencil beam scanning IMPT fields. [PDF]

open access: yes, 2016
PURPOSE A detailed analysis of 2728 intensity modulated proton therapy (IMPT) fields that were clinically delivered to patients between 2007 and 2013 at Paul Scherrer Institute (PSI) was performed.
Lomax, A J   +19 more
core   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Validation of SRS MapCHECK for CyberKnife patient-specific quality assurance: challenges with small cone sizes

open access: yesFrontiers in Oncology
PurposeThe CyberKnife system, designed for stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), considers SRS MapCHECK an effective tool for patient-specific QA (PSQA).
Dohyeon Yoo   +7 more
doaj   +1 more source

Patient‐specific quality assurance of dynamically‐collimated proton therapy treatment plans

open access: yesMedical Physics
AbstractBackgroundThe dynamic collimation system (DCS) provides energy layer‐specific collimation for pencil beam scanning (PBS) proton therapy using two pairs of orthogonal nickel trimmer blades. While excellent measurement‐to‐calculation agreement has been demonstrated for simple cube‐shaped DCS‐trimmed dose distributions, no comparison of ...
Bennett, Laura C.   +16 more
openaire   +2 more sources

Quality Assurance Policies and Indicators for Long-Term Care in the European Union, Country Report: Austria. ENEPRI Research Report No. 105, February 2012 [PDF]

open access: yes, 2012
In Austria, the responsibilities for long-term care mainly lie with the provinces, although federal and organisational-level initiative has grown. Quality assurance policies focus overwhelmingly on the health system and are only slowly appearing in the ...
Kalmar, Marcel   +2 more
core  

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Validation of a patient‐specific quality assurance tool for offline analysis of treatment deliveries

open access: yesMedical Physics
Abstract Background In radiation therapy, Patient‐Specific Quality Assurance (PSQA) is used to ensure safety and accuracy of treatment deliveries, which is paramount to control the disease while safeguarding healthy tissues.
Marie Nasrallah   +6 more
openaire   +3 more sources

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Subject Benchmark Statement: Engineering

open access: yes, 2023
This document is a Quality Assurance Agency for Higher Education (QAA) Subject Benchmark Statement for Engineering that defines what can be expected of a graduate in the subject, in terms of what they might know, do and understand at the end of their ...
The Quality Assurance Agency for Higher Education
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy